New preclinical research shows researchers how to give CD4+ and CD8+ T cells more cancer-fighting power
LA JOLLA—It’s not often that a failed clinical trial leads to a scientific breakthrough. When patients in the UK started
LJI researchers shed light on the role of TET enzymes in genomic stability and cancers
The international recognition reflects how LJI research is valued by scientific peers
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy
New support from the American Cancer Society fuels research into the primary mutations behind many cancer types
National Cancer Institute support brings cancer researchers together to share key findings
Dr. Altman’s research into T cell activation opened the door to new therapies for inflammation, autoimmune diseases, cancers, and more.